French Campaign To Boost Generics Gets Thumbs Up From European Industry Body
The French health ministry is hoping a new campaign aimed at increasing the use of generics and dispelling any remaining doubts about their quality among the public will bring cost savings.
You may also be interested in...
The French pharmaceutical industry has reacted angrily to some of the provisions in the 2017 social security financing bill, arguing that the measures are inappropriate and that the government is taking a purely financial approach to addressing the costs of healthcare products, rather than taking wider public health considerations into account.
The French government has unveiled plans to boost the prescribing and dispensing of generic medicines, with a view to making an additional €350m in savings over the next three years. Most of the measures are aimed at healthcare professionals and the public, although the authorities have called on pharmaceutical firms to help by printing the INN more prominently on product packs.
Industry representatives told a House of Lords committee about continuing Brexit-related problems such as the extra work involved in checking compliance with the EU Falsified Medicines Directive and the drawbacks of a proposed “dual regulatory regime.”